SEARCH:   Advanced

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Taylor, A. Articles by Mak, Y. Search for Related Content PubMed PubMed Citation Articles by Taylor, A. Articles by Mak, Y. Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Leukemia and lymphoma in ataxia telangiectasia AM Taylor, JA Metcalfe, J Thick and YF Mak CRC Institute for Cancer Studies, Medical School, University of Birmingham, UK. There is a large increase in lymphoid malignancy in A-T patients and a total absence of myeloid tumors. Penetrance of the tumor phenotype is about 10% to 15% by early adulthood. The increase in lymphoid malignancy includes both B- and T-cell tumors. However, young A-T patients do not show an increased susceptibility to cALL, and the UK data suggest that B-cell lymphoma occurs in older A-T children. T-cell tumors may occur at any age and may be T-ALL, T-cell lymphoma, or T- PLL; most strikingly, there may be a fourfold to fivefold increased frequency of T-cell tumors compared with that of B-cell tumors in these patients. If this is correct, it is possible that a significant proportion of all T-ALL/T-cell lymphoma in infants might be associated with undiagnosed A-T. The age range and sex predominance for T-ALL may be different for A-T and non-A-T patients and the age range for T-PLL may also be different in A-T and non-A-T patients. There is clearly some uncertainty concerning the ratio of T-cell to B-cell tumors in A- T, but this could be clarified by the publication of all tumors that occur in the disorder. In contrast, 8 of 9 tumors reported in NBS, which shows the same cellular features as A-T, were lymphomas and none was a leukemia. There are several indicators of genetic heterogeneity in A-T that suggest that not all patients are equally susceptible to all T-cell tumor types. Concordance for tumor type within individual families suggests that particular gene defects may be associated with particular tumor types. The logical extrapolation of this argument is that some patients may not have any increased risk for B-cell tumors at all or even to all T-cell types but only to a particular type of T-cell tumor. What is the cause of the increased predisposition to leukemia/lymphoma in A-T patients? There is no evidence that the immunodeficiency in A-T is related to this predisposition. One of the major findings in all A-T patients is the increase in V(D)J-mediated chromosome rearrangement observed in T lymphocytes. Particular chromosome translocations in T cells, involving a break in a TCR gene, are characteristically associated with either T-ALL or T-PLL in non-A-T patients. The majority of T-cell tumors in A-T are T-ALL and T-cell lymphoma, about which virtually nothing is known chromosomally, and the assumption is that the increased number of translocations leads to the increased level of these tumors. In older T patients, the expansion of specific translocation T-cell clones has been followed to the point to which they develop into T-PLL. All the evidence, therefore, suggests that the A-T mutation in the homozygous state allows a large increase in production of translocations formed at the time of V(D)J recombination, and this leads to the increased predisposition to leukemia. The general increased predisposition to T-cell tumors compared with B-cell tumors in A-T patients may be related to a preferential occurrence of translocations in T cells. Relatively little is known about translocations in circulating B lymphocytes in normal individuals, but A-T siblings have been shown to have clonal chromosome rearrangements of both B and T cells, simultaneously, although in these siblings the T-cell clones occupied all the T-cell compartment and the B-cell clones were small. An important inference from these facts is that the A-T defect preferentially affects immune system gene recombination in T cells rather than B cells. Recent evidence suggests that the V(D)J recombination machinery is not identical or is not regulated identically in T- and B-cell progenitors. This finding is consistent with the hypothesis that V(D)J rejoining in the majority, at least, of A-T patients may be preferentially deficient in T cells compared with B cells giving rise to the greatly increased number of translocations and T-cell tumors. Carbonari et al proposed that the recombination defect in A-T cells affected both Ig isotype switching and TCR rearrangeme Volume 87, Issue 2, pp. 423-438, 01/15/1996 Copyright © 1996 by The American Society of Hematology CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: S. L. Bailey, K. E. Gurley, K. Hoon-Kim, K. S. Kelly-Spratt, and C. J. Kemp Tumor Suppression by p53 in the Absence of Atm Mol. Cancer Res., July 1, 2008; 6(7): 1185 - 1192. [Abstract] [Full Text] [PDF] M. Martinez-Gallo, C. Puy, R. Ruiz-Hernandez, J. M. Rodriguez-Arias, M. Bofill, J. F. Nomdedeu, J. C. Cigudosa, J. L. Rodriguez-Sanchez, and O. de la Calle-Martin Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+ CD8+ T-cell leukaemia Eur. Respir. J., June 1, 2008; 31(6): 1368 - 1372. [Abstract] [Full Text] [PDF] E. Le Toriellec, G. Despouy, G. Pierron, N. Gaye, M. Joiner, D. Bellanger, A. Vincent-Salomon, and M.-H. Stern Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia Blood, February 15, 2008; 111(4): 2321 - 2328. [Abstract] [Full Text] [PDF] V. Stagni, M. G. di Bari, S. Cursi, I. Condo, M. T. Cencioni, R. Testi, Y. Lerenthal, E. Cundari, and D. Barila ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells Blood, January 15, 2008; 111(2): 829 - 837. [Abstract] [Full Text] [PDF] K. E. Gurley and C. J. Kemp Ataxia-Telangiectasia Mutated Is Not Required for p53 Induction and Apoptosis in Irradiated Epithelial Tissues Mol. Cancer Res., December 1, 2007; 5(12): 1312 - 1318. [Abstract] [Full Text] [PDF] M. F. Lavin, N. Gueven, S. Bottle, and R. A. Gatti Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia Br. Med. Bull., June 23, 2007; (2007) ldm012v1. [Abstract] [Full Text] [PDF] C.-Y. Huang, G. G. Sharma, L. M. Walker, C. H. Bassing, T. K. Pandita, and B. P. Sleckman Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes J. Exp. Med., June 11, 2007; 204(6): 1371 - 1381. [Abstract] [Full Text] [PDF] I. R. Matei, R. A. Gladdy, L. M. J. Nutter, A. Canty, C. J. Guidos, and J. S. Danska ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes Blood, March 1, 2007; 109(5): 1887 - 1896. [Abstract] [Full Text] [PDF] L.I. Wallis, P.D. Griffiths, S.J. Ritchie, C.A.J. Romanowski, G. Darwent, and I.D. Wilkinson Proton Spectroscopy and Imaging at 3T in Ataxia-Telangiectasia AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 79 - 83. [Abstract] [Full Text] [PDF] R. Reliene and R. H. Schiestl Antioxidants Suppress Lymphoma and Increase Longevity in Atm-Deficient Mice J. Nutr., January 1, 2007; 137(1): 229S - 232S. [Abstract] [Full Text] [PDF] M. Hiromura, F. Suizu, M. Narita, K. Kinowaki, and M. Noguchi Identification of Nerve Growth Factor-responsive Element of the TCL1 Promoter as a Novel Negative Regulatory Element J. Biol. Chem., September 22, 2006; 281(38): 27753 - 27764. [Abstract] [Full Text] [PDF] M. F. Rudd, G. S. Sellick, E. L. Webb, D. Catovsky, and R. S. Houlston Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia Blood, July 15, 2006; 108(2): 638 - 644. [Abstract] [Full Text] [PDF] A M R Taylor and P J Byrd Molecular pathology of ataxia telangiectasia J. Clin. Pathol., October 1, 2005; 58(10): 1009 - 1015. [Abstract] [Full Text] [PDF] C. J. Winrow, D. G. Pankratz, C. R. T. Vibat, T.J. Bowen, M. A. Callahan, A. J. Warren, B. S. Hilbush, A. Wynshaw-Boris, K. W. Hasel, Z. Weaver, et al. Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas Hum. Mol. Genet., September 15, 2005; 14(18): 2671 - 2684. [Abstract] [Full Text] [PDF] D. L. Friedman, N. S. Kadan-Lottick, J. Whitton, A. C. Mertens, Y. Yasui, Y. Liu, A. T. Meadows, L. L. Robison, and L. C. Strong Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1922 - 1927. [Abstract] [Full Text] [PDF] J. M. Lumsden, T. McCarty, L. K. Petiniot, R. Shen, C. Barlow, T. A. Wynn, H. C. Morse III, P. J. Gearhart, A. Wynshaw-Boris, E. E. Max, et al. Immunoglobulin Class Switch Recombination Is Impaired in Atm-deficient Mice J. Exp. Med., November 1, 2004; 200(9): 1111 - 1121. [Abstract] [Full Text] [PDF] M. S. Lim and K. S.J. Elenitoba-Johnson The Molecular Pathology of Primary Immunodeficiencies J. Mol. Diagn., May 1, 2004; 6(2): 59 - 83. [Full Text] [PDF] M. Kuhne, E. Riballo, N. Rief, K. Rothkamm, P. A. Jeggo, and M. Lobrich A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity Cancer Res., January 15, 2004; 64(2): 500 - 508. [Abstract] [Full Text] [PDF] M. Takagi, R. Tsuchida, K. Oguchi, T. Shigeta, S. Nakada, K. Shimizu, M. Ohki, D. Delia, L. Chessa, Y. Taya, et al. Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease Blood, January 1, 2004; 103(1): 283 - 290. [Abstract] [Full Text] [PDF] L. Qi, M. A. Strong, B. O. Karim, M. Armanios, D. L. Huso, and C. W. Greider Short Telomeres and Ataxia-Telangiectasia Mutated Deficiency Cooperatively Increase Telomere Dysfunction and Suppress Tumorigenesis Cancer Res., December 1, 2003; 63(23): 8188 - 8196. [Abstract] [Full Text] [PDF] E. Vazquez, A. Castellote, J. Piqueras, P. Ortuno, J. Sanchez-Toledo, P. Nogues, and J. Lucaya Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis RadioGraphics, September 1, 2003; 23(5): 1155 - 1172. [Abstract] [Full Text] [PDF] J. Starczynski, W. Simmons, J. R. Flavell, P. J. Byrd, G. S. Stewart, H. S. Kullar, A. Groom, J. Crocker, P. A.H. Moss, G. M. Reynolds, et al. Variations in ATM Protein Expression During Normal Lymphoid Differentiation and Among B-Cell-Derived Neoplasias Am. J. Pathol., August 1, 2003; 163(2): 423 - 432. [Abstract] [Full Text] [PDF] K. Oguchi, M. Takagi, R. Tsuchida, Y. Taya, E. Ito, K. Isoyama, E. Ishii, L. Zannini, D. Delia, and S. Mizutani Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement Blood, May 1, 2003; 101(9): 3622 - 3627. [Abstract] [Full Text] [PDF] N. Y. Fang, T. C. Greiner, D. D. Weisenburger, W. C. Chan, J. M. Vose, L. M. Smith, J. O. Armitage, R. A. Mayer, B. L. Pike, F. S. Collins, et al. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma PNAS, April 29, 2003; 100(9): 5372 - 5377. [Abstract] [Full Text] [PDF] Q. Pan-Hammarstrom, S. Dai, Y. Zhao, I. F. van Dijk-Hard, R. A. Gatti, A.-L. Borresen-Dale, and L. Hammarstrom ATM Is Not Required in Somatic Hypermutation of VH, but Is Involved in the Introduction of Mutations in the Switch {micro} Region J. Immunol., April 1, 2003; 170(7): 3707 - 3716. [Abstract] [Full Text] [PDF] Y. Dai, B. Kysela, L. A. Hanakahi, K. Manolis, E. Riballo, M. Stumm, T. O. Harville, S. C. West, M. A. Oettinger, and P. A. Jeggo Nonhomologous end joining and V(D)J recombination require an additional factor PNAS, March 4, 2003; 100(5): 2462 - 2467. [Abstract] [Full Text] [PDF] K. Offit, S. Gilad, S. Paglin, P. Kolachana, L. C. Roisman, K. Nafa, V. Yeugelewitz, M. Gonzales, M. Robson, D. McDermott, et al. Rare Variants of ATM and Risk for Hodgkin's Disease and Radiation-associated Breast Cancers Clin. Cancer Res., December 1, 2002; 8(12): 3813 - 3819. [Abstract] [Full Text] [PDF] A. Giovannetti, F. Mazzetta, E. Caprini, A. Aiuti, M. Marziali, M. Pierdominici, A. Cossarizza, L. Chessa, E. Scala, I. Quinti, et al. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia Blood, December 1, 2002; 100(12): 4082 - 4089. [Abstract] [Full Text] [PDF] M. Yan, X. Kuang, W. Qiang, J. Shen, K. Claypool, W. S. Lynn, and P. K. Y. Wong Prevention of Thymic Lymphoma Development in Atm-/- Mice by Dexamethasone Cancer Res., September 15, 2002; 62(18): 5153 - 5157. [Abstract] [Full Text] [PDF] K. Gronbak, J. Worm, E. Ralfkiaer, V. Ahrenkiel, P. Hokland, and P. Guldberg ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma Blood, July 30, 2002; 100(4): 1430 - 1437. [Abstract] [Full Text] [PDF] M. R. Yuille, A. Condie, C. D. Hudson, P. S. Bradshaw, E. M. Stone, E. Matutes, D. Catovsky, and R. S. Houlston ATM mutations are rare in familial chronic lymphocytic leukemia Blood, June 28, 2002; 100(2): 603 - 609. [Abstract] [Full Text] [PDF] G. Kunstle, J. Laine, G. Pierron, S.-i. Kagami, H. Nakajima, F. Hoh, C. Roumestand, M.-H. Stern, and M. Noguchi Identification of Akt Association and Oligomerization Domains of the Akt Kinase Coactivator TCL1 Mol. Cell. Biol., March 1, 2002; 22(5): 1513 - 1525. [Abstract] [Full Text] [PDF] E. J. Perkins, A. Nair, D. O. Cowley, T. Van Dyke, Y. Chang, and D. A. Ramsden Sensing of intermediates in V(D)J recombination by ATM Genes & Dev., January 15, 2002; 16(2): 159 - 164. [Abstract] [Full Text] [PDF] T. Stankovic, G. S. Stewart, C. Fegan, P. Biggs, J. Last, P. J. Byrd, R. D. Keenan, P. A. H. Moss, and A. M. R. Taylor Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage Blood, January 1, 2002; 99(1): 300 - 309. [Abstract] [Full Text] [PDF] Y. Pekarsky, C. Hallas, and C. M. Croce Molecular Basis of Mature T-Cell Leukemia JAMA, November 14, 2001; 286(18): 2308 - 2314. [Abstract] [Full Text] [PDF] J Boultwood Ataxia telangiectasia gene mutations in leukaemia and lymphoma J. Clin. Pathol., July 1, 2001; 54(7): 512 - 516. [Abstract] [Full Text] [PDF] R. S. Schwartz Immunodeficiency, Immunosuppression, and Susceptibility to Neoplasms J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 5 - 9. [Full Text] [PDF] R. H. Buckley Primary Immunodeficiency Diseases Due to Defects in Lymphocytes N. Engl. J. Med., November 2, 2000; 343(18): 1313 - 1324. [Full Text] [PDF] P.-M. Girard, N. Foray, M. Stumm, A. Waugh, E. Riballo, R. S. Maser, W. P. Phillips, J. Petrini, C. F. Arlett, and P. A. Jeggo Radiosensitivity in Nijmegen Breakage Syndrome Cells Is Attributable to a Repair Defect and not Cell Cycle Checkpoint Defects Cancer Res., September 1, 2000; 60(17): 4881 - 4888. [Abstract] [Full Text] M. Liyanage, Z. Weaver, C. Barlow, A. Coleman, D. G. Pankratz, S. Anderson, A. Wynshaw-Boris, and T. Ried Abnormal rearrangement within the alpha /delta T-cell receptor locus in lymphomas from Atm-deficient mice Blood, September 1, 2000; 96(5): 1940 - 1946. [Abstract] [Full Text] [PDF] A. Cuneo, R. Bigoni, G. M. Rigolin, M. G. Roberti, R. Milani, A. Bardi, C. Minotto, P. Agostini, C. De Angeli, M. G. Narducci, et al. Acquired Chromosome 11q Deletion Involving the Ataxia Teleangiectasia Locus in B-Cell Non-Hodgkin's Lymphoma: Correlation With Clinicobiologic Features J. Clin. Oncol., July 1, 2000; 18(13): 2607 - 2614. [Abstract] [Full Text] [PDF] L. K. Petiniot, Z. Weaver, C. Barlow, R. Shen, M. Eckhaus, S. M. Steinberg, T. Ried, A. Wynshaw-Boris, and R. J. Hodes Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice PNAS, June 6, 2000; 97(12): 6664 - 6669. [Abstract] [Full Text] [PDF] E. Macintyre, D. Willerford, and S. W. Morris Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma Hematology, January 1, 2000; 2000(1): 180 - 204. [Abstract] [Full Text] [PDF] G. J. Vanasse, P. Concannon, and D. M. Willerford Regulated Genomic Instability and Neoplasia in the Lymphoid Lineage Blood, December 15, 1999; 94(12): 3997 - 4010. [Full Text] [PDF] T. Fukao, H. Kaneko, G. Birrell, M. Gatei, H. Tashita, T. Yoshida, S. Cross, P. Kedar, D. Watters, K. K. Khana, et al. ATM Is Upregulated During the Mitogenic Response in Peripheral Blood Mononuclear Cells Blood, September 15, 1999; 94(6): 1998 - 2006. [Abstract] [Full Text] [PDF] C. Schaffner, S. Stilgenbauer, G. A. Rappold, H. Dohner, and P. Lichter Somatic ATM Mutations Indicate a Pathogenic Role of ATM in B-Cell Chronic Lymphocytic Leukemia Blood, July 15, 1999; 94(2): 748 - 753. [Abstract] [Full Text] [PDF] J. Peake, A. Waugh, F. Le Deist, A. Priestley, F. Rieux-Laucat, N. Foray, E. Capulas, B. K. Singleton, J.-P. de Villartay, A. Cant, et al. Combined Immunodeficiency Associated with Increased Apoptosis of Lymphocytes and Radiosensitivity of Fibroblasts Cancer Res., July 1, 1999; 59(14): 3454 - 3460. [Abstract] [Full Text] [PDF] R. G. Wickremasinghe and A. V. Hoffbrand Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies Blood, June 1, 1999; 93(11): 3587 - 3600. [Full Text] [PDF] M.-J. Liao and T. Van Dyke Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma Genes & Dev., May 15, 1999; 13(10): 1246 - 1250. [Abstract] [Full Text] K. E. Nichols, S. Levitz, K. E. Shannon, D. C.R. Wahrer, D. W. Bell, G. Chang, S. Hegde, D. Neuberg, T. Shafman, N. J. Tarbell, et al. Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease J. Clin. Oncol., April 1, 1999; 17(4): 1259 - 1259. [Abstract] [Full Text] [PDF] M.-J. Liao, C. Yin, C. Barlow, A. Wynshaw-Boris, and T. van Dyke Atm Is Dispensable for p53 Apoptosis and Tumor Suppression Triggered by Cell Cycle Dysfunction Mol. Cell. Biol., April 1, 1999; 19(4): 3095 - 3102. [Abstract] [Full Text] [PDF] C. Retiere, F. Halary, M.-A. Peyrat, F. Le Deist, M. Bonneville, and M.-M. Hallet The Mechanism of Chromosome 7 Inversion in Human Lymphocytes Expressing Chimeric {gamma}{beta} TCR J. Immunol., January 15, 1999; 162(2): 903 - 910. [Abstract] [Full Text] [PDF] F. Bullrich, D. Rasio, S. Kitada, P. Starostik, T. Kipps, M. Keating, M. Albitar, J. C. Reed, and C. M. Croce ATM Mutations in B-Cell Chronic Lymphocytic Leukemia Cancer Res., January 1, 1999; 59(1): 24 - 27. [Abstract] [Full Text] [PDF] C. Gritti, H. Dastot, J. Soulier, A. Janin, M.-T. Daniel, A. Madani, G. Grimber, P. Briand, F. Sigaux, and M.-H. Stern Transgenic Mice for MTCP1 Develop T-Cell Prolymphocytic Leukemia Blood, July 15, 1998; 92(2): 368 - 373. [Abstract] [Full Text] [PDF] M.-J. Liao, X.-X. Zhang, R. Hill, J. Gao, M. B. Qumsiyeh, W. Nichols, and T. Van Dyke No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma Mol. Cell. Biol., June 1, 1998; 18(6): 3495 - 3501. [Abstract] [Full Text] D. Stoppa-Lyonnet, J. Soulier, A. Lauge, H. Dastot, R. Garand, F. Sigaux, and M.-H. Stern Inactivation of the ATM Gene in T-Cell Prolymphocytic Leukemias Blood, May 15, 1998; 91(10): 3920 - 3926. [Abstract] [Full Text] [PDF] L. Virgilio, C. Lazzeri, R. Bichi, K.-i. Nibu, M. G. Narducci, G. Russo, J. L. Rothstein, and C. M. Croce Deregulated expression of TCL1 causes T cell leukemia in mice PNAS, March 31, 1998; 95(7): 3885 - 3889. [Abstract] [Full Text] [PDF] F. M. Uckun, M. G. Sensel, L. Sun, P. G. Steinherz, M. E. Trigg, N. A. Heerema, H. N. Sather, G. H. Reaman, and P. S. Gaynon Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia Blood, February 1, 1998; 91(3): 735 - 746. [Full Text] [PDF] R. O. Kuljis, Y. Xu, M. C. Aguila, and D. Baltimore Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia PNAS, November 11, 1997; 94(23): 12688 - 12693. [Abstract] [Full Text] [PDF] K.A. Rack, F. Cornelis, I. Radford-Weiss, A. Bernheim, C.J. Harrison, O. Hermine, M. Prieur, M. Vekemans, and E.A. Macintyre A Chromosome 14q11/TCRalpha /delta Specific Yeast Artificial Chromosome Improves the Detection Rate and Characterization of Chromosome Abnormalities in T-Lymphoproliferative Disorders Blood, August 1, 1997; 90(3): 1233 - 1240. [Abstract] [Full Text] [PDF] K. D. Brown, Y. Ziv, S. N. Sadanandan, L. Chessa, F. S. Collins, Y. Shiloh, and D. A. Tagle The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage PNAS, March 4, 1997; 94(5): 1840 - 1845. [Abstract] [Full Text] [PDF] A. M. Ford, M. S. Pombo-de-Oliveira, K. P. McCarthy, J. M. MacLean, K. C. Carrico, R. F. Vincent, and M. Greaves Monoclonal Origin of Concordant T-Cell Malignancy in Identical Twins Blood, January 1, 1997; 89(1): 281 - 285. [Abstract] [Full Text] [PDF] G. Chen and E. Y.-H. P. Lee The Product of the ATM Gene Is a 370-kDa Nuclear Phosphoprotein J. Biol. Chem., December 27, 1996; 271(52): 33693 - 33697. [Abstract] [Full Text] [PDF] A. Elson, Y. Wang, C. J. Daugherty, C. C. Morton, F. Zhou, J. Campos-Torres, and P. Leder Pleiotropic defects in ataxia-telangiectasia protein-deficient mice PNAS, November 12, 1996; 93(23): 13084 - 13089. [Abstract] [Full Text] [PDF] J. T. Sandlund, J. R. Downing, and W. M. Crist Non-Hodgkin's Lymphoma in Childhood N. Engl. J. Med., May 9, 1996; 334(19): 1238 - 1248. [Full Text] [PDF] C. Schaffner, I. Idler, S. Stilgenbauer, H. Dohner, and P. Lichter Mantle cell lymphoma is characterized by inactivation of the ATM gene PNAS, March 14, 2000; 97(6): 2773 - 2778. [Abstract] [Full Text] [PDF] P. R. Borghesani, F. W. Alt, A. Bottaro, L. Davidson, S. Aksoy, G. A. Rathbun, T. M. Roberts, W. Swat, R. A. Segal, and Y. Gu From the Cover: Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice PNAS, March 28, 2000; 97(7): 3336 - 3341. [Abstract] [Full Text] [PDF]

	Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020